secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2026-05-01T23:59:59+00:00
Accession:  0001021771-26-000068
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative Therapies approves 2025 executive bonuses; CEO bonus $300K, VP $287.5K, CFO $140K
--------------------------------------------------------------------------------

- CEO Lance Alstodt awarded $300K cash bonus and $1.5M in option awards; total 2025 compensation $2.4M.
- VP Francisco Silva gets $287.5K bonus plus $1.47M in options; total 2025 comp $2.3M.
- CFO Robert Kristal awarded $140K bonus and $318K in options; total 2025 comp $801,750.
- All bonuses are discretionary for 2025 services, payable in 2026; total compensation up significantly from 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000102177126000068/0001021771-26-000068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000102177126000068/brtx-20260501.htm
  HTML page:      https://secwatch.observer/filing/0001021771-26-000068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer